• Farmacosmo's board met on October 28, 2026, authorizing a framework for product purchases from Gargiulo & Maiello.
• The authorization runs for one year from approval, with purchases capped at EUR 10 million.
• Directors voted unanimously among those participating, with Alessandro Maiello abstaining; he controls the supplier.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Farmacosmo S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 159676.pdf), on November 02, 2026, and is solely responsible for the information contained therein.